Mayor Brandon Scott on Thursday unveiled the terms of last month's settlement between the city and Walgreens, which will bring in tens of millions of dollars for local opioid remediation programs.
The settlement over the company's role in the opioid epidemic, one of five reached this year, totaled $80 million. The city will receive $45 million by the end of the year and the remainder by the end of 2025, according to the news release.
The city has earmarked $35 million from the settlement for local harm reduction programs, including $15 million for the city to establish "comprehensive outreach services" that operate 24/7, $10 million for the Baltimore Comprehensive Overdose Response to End the Epidemic, also known as BCORE, and $5 million for 988 education and outreach.
In addition, the city will dedicate $1 million to We Our Us; $1 million to On Our Own of Maryland; and $1 million to the Maryland Coalition of Families.
The city is slated to receive $402.5 million in total from opioid settlements this year. That does not include the Johnson & Johnson settlement last month, as its terms still have not been released.
Attorneys representing the city are also in the middle of an eight-week trial with McKesson and Censora, formerly called AmerisourceBergen, with hopes of reaching a much larger settlement.
Baltimore has so far dedicated $107 million in settlement funds to local programs and the Baltimore City Health Department, as stipulated by the agreements.
Although it's unclear how much the city spent on attorneys, officials have said one-third of settlement funds will go to legal fees — except for the $20 million used for fees related to the city's settlement with Allergan earlier this year.
All remaining funds will be disbursed through a new governance structure that Scott unveiled last month.
Comments